The role of insulin-like growth factor I in growth of diabetic rats

Acta Endocrinol (Copenh). 1989 Nov;121(5):628-32. doi: 10.1530/acta.0.1210628.

Abstract

Insulin-deficient, streptozotocin-diabetic rats show severe metabolic disturbances and stop growing. Besides insulin, these animals also lack growth hormone and insulin-like growth factor-I. We examined whether or not growth parameters correlate with IGF-I serum levels in young rats with streptozotocin-diabetes of different severity. In the diabetic rats, blood glucose varied between 18.4 and 38.6 mmol/l (healthy controls between 6.1 and 9.3), IGF-I serum levels between 2.6 and 15.6 nmol/l (controls between 19.6 and 26.5), and serum insulin levels between 0.05 and 0.14 nmol/l (controls between 0.36 and 0.55). We found a highly significant linear correlation between IGF-I serum levels and the two investigated growth parameters, tibial epiphyseal width and longitudinal tibial bone growth. The finding that these indices of growth are strongly correlated with IGF-I serum levels in young rats with diabetes of different severity, suggests that IGF-I is a major determinant of growth. This is in keeping with our earlier demonstration that exogenously infused IGF-I promotes growth in diabetic rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Development*
  • Diabetes Mellitus, Experimental / blood*
  • Diabetes Mellitus, Experimental / physiopathology
  • Insulin-Like Growth Factor I / blood*
  • Male
  • Radioimmunoassay
  • Rats
  • Rats, Inbred Strains
  • Somatomedins / blood*
  • Tibia / growth & development

Substances

  • Somatomedins
  • Insulin-Like Growth Factor I